Structured evidence table for Probiotics, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Probiotics | In this scoping review, the evidence on the role of Lactobacillus- and Bifidobacterium-based probiotic supplementation in managing GDM is mapped systematically, and knowledge gaps and future research directions are identified. | 3 | Uzair SA (2026) | Elucidating the Probiotic Potential of Lactobacillus and Bifidobacterium Species in Modulating Glucose Metabolism and Inflammation in Gestational Diabetes Mellitus: A Scoping Review. |
| Probiotics | The findings consistently showed improvements in fasting glucose levels, insulin sensitivity, and reduction in serum insulin levels and homeostatic model assessment for insulin resistance with increased Quantitative Insulin Sensitivity Check Index scores. | 3 | Uzair SA (2026) | Elucidating the Probiotic Potential of Lactobacillus and Bifidobacterium Species in Modulating Glucose Metabolism and Inflammation in Gestational Diabetes Mellitus: A Scoping Review. |
| Probiotics | The evidence indicates the potential of Lactobacillus- and Bifidobacterium-based probiotic interventions to beneficially influence glucose metabolism, inflammatory response, and gut microbial balance in GDM. | 3 | Uzair SA (2026) | Elucidating the Probiotic Potential of Lactobacillus and Bifidobacterium Species in Modulating Glucose Metabolism and Inflammation in Gestational Diabetes Mellitus: A Scoping Review. |
| Probiotics | Gestational diabetes mellitus (GDM) affects 14% of pregnancies globally, contributing to gut microbial dysbiosis, inflammation, and insulin resistance. | 3 | Uzair SA (2026) | Elucidating the Probiotic Potential of Lactobacillus and Bifidobacterium Species in Modulating Glucose Metabolism and Inflammation in Gestational Diabetes Mellitus: A Scoping Review. |
| Probiotics | Gut microbiota, immune parameters and, in turn, psoriasis symptom improvement have recently been associated with the use of probiotics in several different studies. | 3 | Ayuningtyas M (2026) | The Effectiveness of Probiotics in Psoriasis: An Umbrella Review. |
| Probiotics | Probiotics are associated with significantly reduced Psoriasis Area and Severity Index (PASI) scores, increased PASI 75 response rates, lowered inflammatory biomarkers (CRP, TNFα, IL-6) and improved Dermatology Life Quality Index (DLQI). | 3 | Ayuningtyas M (2026) | The Effectiveness of Probiotics in Psoriasis: An Umbrella Review. |
| Probiotics | Greater effectiveness was found with multistrain probiotics, treatment duration of ≥ 12 weeks and studies conducted in Asia. | 3 | Ayuningtyas M (2026) | The Effectiveness of Probiotics in Psoriasis: An Umbrella Review. |
| Probiotics | Background Psoriasis is an immune-mediated inflammatory skin condition that is chronic and causes a great deal of disease burden, especially for those affected in their most productive years. | 3 | Ayuningtyas M (2026) | The Effectiveness of Probiotics in Psoriasis: An Umbrella Review. |
Source documents